Page last updated: 2024-12-06

erythromycin propionate-n-acetylcysteinate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID71276
SCHEMBL ID419684
MeSH IDM0160905

Synonyms (23)

Synonym
erythromycin stinoprate
D07910
84252-03-9
erysec (tn)
erythromycin stinoprate (inn)
estinoprato de eritromicina [spanish]
erythromycin propionate-n-acetylcysteinate
stinoprate d'erythromycie [french]
estinoprato de eritromicina
erythromycin stinoprate [inn]
erythromycini stinopras
erythromycini stinopras [latin]
stinoprate d'erythromycie
unii-m6s6o570yo
erythromycin 2'-propionate, compound with n-acetyl-l-cysteine (1:1)
m6s6o570yo ,
AKOS015896271
erythromycin stinoprate [who-dd]
erysec
SCHEMBL419684
erythromycinstinoprat
(2r)-2-acetamido-3-sulfanylpropanoic acid;[(2s,3r,4s,6r)-4-(dimethylamino)-2-[[(3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetra
Q27283563

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" EPAC showed a better bioavailability than ES with longer-lasting serum levels of active antibiotic."( Human pharmacokinetics of erythromycin propionate-N-acetylcysteinate: comparative evaluation with erythromycin stearate and N-acetylcysteine.
De Bernardi, M; Feletti, F; Fregnan, GB; Gazzani, G, 1988
)
0.58
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.06)18.7374
1990's0 (0.00)18.2507
2000's8 (24.24)29.6817
2010's20 (60.61)24.3611
2020's3 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.09 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (6.06%)5.53%
Reviews4 (12.12%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other27 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]